News about Industrial talks

Adroit Biomed expands its immunity portfolio with launch of Glutone MD made from purest Setria Glutathione

Management of patient's recovery from effects of COVID 19 is the key focus point to going back to normalcy. To help the patient recover faster, Mumbai based Pharma, Healthcare & Nutraceutical supplement maker Adroit Biomed Limited today launched its immunity enhancing tablets Glutone MD

Industrial talks | 30/06/2021 | By Darshana |  585

Rockwell partners with Dr Reddy's Labs to provide WHO PQS certified Covid-19 vaccine freezers to store Sputnik V vaccine

Rockwell Industries, a commercial cold chain appliance manufacturer, has entered into a strategic partnership with Dr Reddy's Laboratories (DRL), to provide its WHO PQS (World Health Organisation - Performance, Quality and Safety) certified Covid-19 vaccine freezers to enable storage of Sputnik V vaccine across India

Industrial talks | 09/06/2021 | By Darshana |  283

Trivitron Healthcare launches advanced diagnostic solutions for HbA1c based on HPLC technology

Trivitron Healthcare has launched two new products "NANO H5 and NANO H110" for HbA1c- and Hb- variant detection. These products are High Performace Liquid Chromatography (HPLC) analysers for HbA1c detection in less than three minutes. These will be used for monitoring diabetes, thalassemia and haemoglobin variants, a company statement said

Industrial talks | 02/06/2021 | By Darshana |  397

Sun Pharma acquires rights to trademarks of three diabetes drug brands in India from AstraZeneca

Sun Pharmaceutical Industries Ltd has acquired the rights to trademarks of diabetes drug dapagliflozin under brands Oxra, Oxramet and Oxraduo in India from AstraZeneca AB, Sweden, the parent company of AstraZeneca Pharma India

Industrial talks | 30/05/2021 | By Darshana |  600

PharmEasy completes acquisition of Medlife

The acquisition which took place in January 2021, was aimed at creating a strong unified platform to accelerate the mission of providing quality healthcare to a larger population

Industrial talks | 26/05/2021 | By Darshana |  361

Bharat Biotech expects WHO emergency listing for Covaxin by July-September 2021

Bharat Biotech stated that it has submitted application for WHO Emergency Use Listing (EUL) for Covaxin, and regulatory approvals are expected in July-September, 2021

Industrial talks | 26/05/2021 | By Darshana |  199

Moderna, Aldevron extends partnership for mRNA vaccine and therapeutic pipeline

Moderna, Inc., a biotechnology company pioneering messenger RNA therapeutics and vaccines, and Aldevron, LLC, the leading provider of high-quality plasmid DNA, mRNA and recombinant proteins necessary for vaccines, gene and cell therapy, gene editing and diagnostic applications, have announced their expanded collaboration in support of the Moderna

Industrial talks | 25/05/2021 | By Darshana |  272

RDIF in discussions on production of Sputnik V for other countries, Dr Reddy's

Dr Reddy's Laboratories, which is in a pact with Russian Direct Investment Fund to sell 125 million people doses (250 million vials) of COVID-19 vaccine Sputnik V in India, is holding parleys with RDIF for acquiring rights for more countries, a senior official of the Indian company said. Dr Reddy's, which had received over two lakh vaccines from RDIF

Industrial talks | 20/05/2021 | By Darshana |  224

Biomay Cooperates with BioNTech to Supply DNA Template for COVID-19 mRNA Vaccine

Biomay, a Vienna based biotech manufacturer, today announced their partnership with BioNTech SE to support the supply chain for manufacturing of the Pfizer-BioNTech COVID-19 mRNA vaccine. Biomay is one of the manufacturers supplying BioNTech with the DNA template for the in-vitro transcription of their mRNA active ingredient

Industrial talks | 19/05/2021 | By Darshana |  309

Shilpa Medicare arm collaborates with Dr Reddy's Labs for production of Sputnik V vaccine

Shilpa Medicare Limited via its wholly owned subsidiary Shilpa Biologicals Private Limited (SBPL), has entered into a 3 year definitive agreement with Dr Reddy's Laboratories Limited (DRL) for production-supply of the Sputnik V vaccine from its integrated biologics R&D cum manufacturing center at Dharwad, Karnataka

Industrial talks | 18/05/2021 | By Darshana |  211